News for 'Laboratories Inc'

Ranbaxy to appeal against quinapril order

Ranbaxy to appeal against quinapril order

Rediff.com30 Mar 2005

Ranbaxy Laboratories will file an appeal against a New Jersey district court order restraining Teva Pharmaceuticals and Ranbaxy Pharmaceuticals Inc from selling RPI's quinapril tablets (5, 10, 20, and 40 mg) on a challenge filed by Pfizer.

Dr.Reddy's buys US firm Trigenesis

Dr.Reddy's buys US firm Trigenesis

Rediff.com6 May 2004

Dr.Reddy's Laboratories has acquired Trigenesis Therapeutics Inc, a United States based privately owned dermatology company, with a total investment outlay of $11 million.

Ranbaxy, Cephalon settle patent case

Ranbaxy, Cephalon settle patent case

Rediff.com23 Dec 2005

Close on the heels of a US district court ruling against its patent challenge of Pfizer's Lipitor, Ranbaxy Laboratories Ltd on Friday said it had entered into an out of court settlement with Cephalon Inc

Covid-19 impact: Textile, paint makers roll out antiviral layer to ads

Covid-19 impact: Textile, paint makers roll out antiviral layer to ads

Rediff.com24 Nov 2020

Almost each of these companies has a different technology to show for the effectiveness against microbes.

Ranbaxy bags cardio drug deal

Ranbaxy bags cardio drug deal

Rediff.com10 Dec 2004

Pfizer may merge Duchem with itself

Pfizer may merge Duchem with itself

Rediff.com24 Apr 2006

Ranbaxy's diabetes drug gets US FDA nod

Ranbaxy's diabetes drug gets US FDA nod

Rediff.com22 Jun 2004

Ranbaxy on Tuesday announced it had got final approval from the US Food and Drug Administration to market its Metformin HC1 tablets for diabetes.

Ranbaxy unveils Riomet in US

Ranbaxy unveils Riomet in US

Rediff.com11 Feb 2004

Morepen expects sales to rise by Rs 100 cr

Morepen expects sales to rise by Rs 100 cr

Rediff.com11 Feb 2003

Morepen Laboratories is all set to gain from the 180-day marketing exclusivity granted to Geneva Pharmaceuticals Inc for Loratadine in the U S.

Ranbaxy enters into licensing pact with EPIRUS Switzerland

Ranbaxy enters into licensing pact with EPIRUS Switzerland

Rediff.com9 Jan 2014

EPIRUS Switzerland GmbH is a wholly-owned subsidiary of Boston-based Epirus Biopharmaceuticals, Inc.

Ranbaxy gets US nod for Ofloxacin

Ranbaxy gets US nod for Ofloxacin

Rediff.com3 Sep 2003

Indian drug major Ranbaxy Laboratories has got the US Food and Drug Administration nod for the manufacture and sale of Ofloxacin tablets.

Ranbaxy gets final FDA nod for drug

Ranbaxy gets final FDA nod for drug

Rediff.com10 Jun 2004

Ranbaxy Laboratories on Thursday said that it had received final approval from US Food and Drug Administration to manufacture and market Ciprofloxacin.

Ranbaxy gets USFDA nod for Ofloxacin

Ranbaxy gets USFDA nod for Ofloxacin

Rediff.com20 Jun 2003

Ranbaxy Laboratories on Friday said it has received tentative approval from US Food and Drug Administration to manufacture and market Ofloxacin, the generic version of Ortho Mcneil Pharmaceutical Inc's Floxin.

Aventis sues Dr Reddy's

Aventis sues Dr Reddy's

Rediff.com27 Mar 2003

Ranbaxy gets FDA nod for Isotretinoin capsules

Ranbaxy gets FDA nod for Isotretinoin capsules

Rediff.com23 Jun 2003

Ranbaxy Laboratories on Monday said it has received the US Food and Drug Administration's approval to manufacture and market Isotretinoin capsules, a generic version of Hoffman LaRoche's Accutane.

As 4G network rolls in, this is the right time to be in India: Cook

As 4G network rolls in, this is the right time to be in India: Cook

Rediff.com19 May 2016

India is world's third-largest smartphone market with over 100 million smartphones sold last year.

COVID-19 second wave: Delays in RT-PCR tests

COVID-19 second wave: Delays in RT-PCR tests

Rediff.com9 May 2021

While there is a shortage of testing kits, manpower and capacities, India does not have other scalable testing options.

Delhi HC extends relief to pharma firms in drug ban case

Delhi HC extends relief to pharma firms in drug ban case

Rediff.com21 Mar 2016

Several companies, including Indian units of Abbott Laboratories and Pfizer Inc, and domestic firms like Cipla Ltd and Macleods Pharmaceuticals, went to the Delhi High Court to try to get the ban lifted.

India may take WTO action against EU over drug clinical trials

India may take WTO action against EU over drug clinical trials

Rediff.com15 Apr 2015

GVK Biosciences is the latest Indian firm to come under international scrutiny over quality issues.

Pharma in 2014: Deals worth billions and fines worth millions

Pharma in 2014: Deals worth billions and fines worth millions

Rediff.com26 Dec 2014

In a surprise announcement in April, Sun and Ranbaxy -- at that time owned by Japan's Daiichi -- declared an all-stock deal to create India's largest and world's fifth-largest drugmaker in an over $4 billion deal.

Pfizer, Ranbaxy win dismissal of lawsuit over generic Lipitor

Pfizer, Ranbaxy win dismissal of lawsuit over generic Lipitor

Rediff.com13 Sep 2014

Pfizer Inc and Ranbaxy Laboratories Ltd on Friday won dismissal of a U.S. antitrust lawsuit accusing them of conspiring to delay sales of generic versions of the best-selling cholesterol drug Lipitor.

Ranbaxy's top executives in the US resign

Ranbaxy's top executives in the US resign

Rediff.com14 Oct 2014

US country head, key departmental heads leave; more likely to follow.

Modi govt plans to make medicines cheaper

Modi govt plans to make medicines cheaper

Rediff.com24 Jun 2014

The health ministry has formed a committee to consider raising the number of drugs deemed essential and subject to price caps.

Walmart's $16 bn Flipkart buy is the biggest deal this year

Walmart's $16 bn Flipkart buy is the biggest deal this year

Rediff.com9 May 2018

Sachin Bansal, who had co-founded Flipkart with Binny Bansal in 2007, would exit the company

Microsoft co-founder, Jimi Hendrix fan, sports team owner... The incredible life and times of Paul Allen

Microsoft co-founder, Jimi Hendrix fan, sports team owner... The incredible life and times of Paul Allen

Rediff.com18 Oct 2018

Whenever you think of Microsoft, the only name that crosses one's mind is Bill Gates. But the tech behemoth was co-founded in 1975 by Gates and Paul Allen.

Study finds GM ingredients in packaged foods in India

Study finds GM ingredients in packaged foods in India

Rediff.com27 Jul 2018

The study also found that most GM foods did not disclose the fact on the label. "A few also made false claims of being GM-free," the study by CSE said.

Delhi-born Raja Krishnamorthi elected to US Congress

Delhi-born Raja Krishnamorthi elected to US Congress

Rediff.com9 Nov 2016

Krishnamoorthi, 43, won the Chicago-area US House of Representatives seat, the 8th Congressional District, vacated by Tammy Duckworth who won Illinois's US Senate seat.

FIPB clears GlaxoSmithKline's Rs 6,400-crore FDI proposal

FIPB clears GlaxoSmithKline's Rs 6,400-crore FDI proposal

Rediff.com13 Jan 2014

The Singapore subsidiary of the UK-based GlaxoSmithKline plans to buy 24.33 per cent stake or 2.06 crore equity shares in GlaxoSmithKline Pharmaceuticals Ltd through an open offer.

Lupin gets USFDA nod for additonal strengths of cholesterol drug

Lupin gets USFDA nod for additonal strengths of cholesterol drug

Rediff.com22 Oct 2013

The company has received final approval for its supplemental New Drug Application (sNDA) for Antara (Fenofibrate) capsules in 30 mg and 90 mg strengths from the United States Food and Drug Administration (USFDA), Lupin Ltd said in a statement.

Sun Pharma open to large acquisitions post Ranbaxy

Sun Pharma open to large acquisitions post Ranbaxy

Rediff.com25 Mar 2015

Sun Pharma open to large acquisitions post Ranbaxy.

Volkswagen's recall letters in April warned of an emissions glitch

Volkswagen's recall letters in April warned of an emissions glitch

Rediff.com24 Sep 2015

The controversy came to public attention last week after Volkswagen acknowledged it had deliberately deceived officials about how much its diesel cars polluted.

How Anant Agrawal built edX into a global giant

How Anant Agrawal built edX into a global giant

Rediff.com4 Sep 2020

'Many who have experimented with online education will adopt a blended model once things return to normal,' edX CEO and founder Anant Agrawal tells Anjuli Bhargava.

New drug policy, regulations slowing down pharma growth

New drug policy, regulations slowing down pharma growth

Rediff.com31 Oct 2013

Hit by the new drug pricing policy and regulatory interventions, growth rate of the Rs 72,069-crore Indian pharmaceutical market has slowed down to 9.8 per cent in 2013 as compared to 16.6 per cent in 2012, says a report.

Mid-, small-cap stocks on a roll but experts see bubble ahead

Mid-, small-cap stocks on a roll but experts see bubble ahead

Rediff.com23 Aug 2016

market rally, especially in mid-caps, has also been driven by a pick-up in the monsoon and the government's resolve to get the goods and services tax (GST) Bill cleared in the recent session of Parliament.

Bankruptcy bill passage enthuse markets; Nifty settles at 7,900

Bankruptcy bill passage enthuse markets; Nifty settles at 7,900

Rediff.com12 May 2016

Participants are eagerly waiting for the key macrodata -- IIP and CPI numbers due to be released later today.

Markets make handsome gains on December F&O expiry

Markets make handsome gains on December F&O expiry

Rediff.com31 Dec 2015

The top gainers on the Sensex are Gail(India), HDFC, Infosys.

Markets end at fresh 13-month lows as global stocks derail

Markets end at fresh 13-month lows as global stocks derail

Rediff.com4 Sep 2015

After a volatile session, Sensex closed the day 563 points lower

Sensex ends 190 points higher led by Infosys; Nifty reclaims 7,900

Sensex ends 190 points higher led by Infosys; Nifty reclaims 7,900

Rediff.com18 Apr 2016

Top gainers from the Sensex pack are Infosys, Cipla, NTPC, ITC and Lupin